AIRA is building the new era of clinical development with a unified AI platform for trial design and protocol development.

The platform enables biopharma teams to collaborate with expert-level AI thought partners across clinical, regulatory, statistical strategy, and medical writing domains. AIRA orchestrates 100+ custom-trained models and algorithms to support the full study design lifecycle.

Biopharma companies in the U.S. use AIRA to shorten timelines by months and save hundreds of thousands of dollars per study - accelerating programs and helping therapies reach patients sooner and safer.

AIRA Health

Org chart

Teams

Offices